Evozym Biologics
Lewes
About Evozym Biologics
Evozym Biologics, Inc. develops a platform technology that utilizes biology with multi-core computation, algorithms, databases, and biological engineering to transform the evolution of known gene profiles into novel proteins. It produces viable enzyme and protein candidates that perform in specific environmental conditions for industrial applications. The company’s enhanced enzyme technology includes protein and enzyme optimization, and novel compound development for applications in biofuels, biopharmaceuticals, cleaning compounds, and bioremediation. Its computational platform optimizes the structure and function of proteins, as well as enables an output of a portfolio of genomics products for applications in renewable energy, human health, industrial green chemistry, and environmental remediation. The company was founded in 2009 and is based in Lewes, Delaware.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $600.0K
- Funding stage: Seed
- Last round: Seed (Dec 2011)
- Website: evozym.com
- Phone: 302-249-5458
Industries & Categories
Biotechnology, Genetics
Canonical: https://fsome.com/organization/evozym-biologics-2206037 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.